Prevalence of Non-AIDS Comorbidities and Factors Associated with Metabolic Complications Among HIV-Infected Patients at a Thai Referral Hospital

Overview

Journal J Int Assoc Provid AIDS Care

Publisher Sage Publications

Specialty Infectious Diseases

Date 2018 Jan 24

PMID 29357771

Citations 6

Authors

Chotirat Nakaranurack

Weerawat Manosuthi

Affiliations

Soon will be listed here.

Abstract

Objectives: The prevalence of non-AIDS-related comorbidities is increasing in HIV-infected patients receiving antiretroviral therapy. In Thailand, data regarding the prevalence of non-AIDS comorbidities and factors associated with metabolic complications in HIV-infected patients have not been well-documented.

Methods: This cross-sectional study was conducted in 2011 and included 874 HIV-infected patients.

Results: The age of patients was 45(8) years represented as mean (standard deviation [SD]). The current CD4 count was 502(247) cells/mm. In all, 388 (44%) of the included patients had at least 1non-AIDS comorbidity. The most frequently documented comorbidities were hyperlipidemia in 271 (70%) patients. Using multivariate analysis, older age(odds ratio [OR] = 1.82, 95% confidence interval [CI] = 1.51-2.19), male sex (OR = 1.55, 95%CI = 1.14-2.11), high current CD4 count(OR = 1.00, 95%CI = 1.00-1.00), and taking abacavir (ABC)-containing(OR = 2.59, 95%CI = 1.16-5.78)and didanosine (ddI)-containing antiretroviral regimens (OR = 4.16, 95%CI = 1.09-15.84)were associated with the presence of metabolic complications (all Ps<.05).

Conclusion: The prevalence of comorbidities is substantially high. Clinical monitoring and effective management of these comorbidities and metabolic complications are recommended, especially in HIV-infected patients who present with these associated factors.

Citing Articles

Traditional complementary and alternative medicine (TCAM) use among PLHIV on antiretroviral medication.

Denu M, Buadu M, Adrah F, Normeshie C, Berko K AIDS Res Ther. 2024; 21(1):84.

PMID: 39567958 PMC: 11580185. DOI: 10.1186/s12981-024-00673-w.

Treatment with Antiviral Drugs Will Significantly Inhibit the HIV-1 RNA POL Gene Expression and Viral Load in AIDS Patients.

Shi P, Wang X, Su M, Meng J, Wang H, Fan W Dis Markers. 2023; 2023:9910542.

PMID: 37091892 PMC: 10121356. DOI: 10.1155/2023/9910542.

Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review.

Ruamtawee W, Tipayamongkholgul M, Aimyong N, Manosuthi W BMC Public Health. 2023; 23(1):477.

PMID: 36915099 PMC: 10009940. DOI: 10.1186/s12889-023-15321-7.

Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.

Yang X, Zhang J, Chen S, Weissman S, Olatosi B, Li X AIDS. 2021; 35(Suppl 1):S39-S51.

PMID: 33867488 PMC: 8058944. DOI: 10.1097/QAD.0000000000002736.

Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets.

Madzime M, Rossouw T, Theron A, Anderson R, Steel H Front Immunol. 2021; 12:634386.

PMID: 33777022 PMC: 7994251. DOI: 10.3389/fimmu.2021.634386.

References

Wu P, Chen M, Hsieh S, Sun H, Tsai M, Lee K . Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan. PLoS One. 2014; 9(8):e104945. PMC: 4132082. DOI: 10.1371/journal.pone.0104945. View

Bavinger C, Bendavid E, Niehaus K, Olshen R, Olkin I, Sundaram V . Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. PLoS One. 2013; 8(3):e59551. PMC: 3608726. DOI: 10.1371/journal.pone.0059551. View

Max B, Sherer R . Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000; 30 Suppl 2:S96-116. DOI: 10.1086/313859. View

Aekplakorn W, Stolk R, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S . The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care. 2003; 26(10):2758-63. DOI: 10.2337/diacare.26.10.2758. View

Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M . Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011; 53(11):1130-9. DOI: 10.1093/cid/cir626. View

Pumpradit W, Ananworanich J, Lolak S, Shikuma C, Paul R, Siangphoe U . Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol. 2010; 16(1):76-82. DOI: 10.3109/13550280903493914. View

Peters B, Post F, Wierzbicki A, Phillips A, Power L, Das S . Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach. HIV Med. 2012; 14 Suppl 1:1-11. DOI: 10.1111/j.1468-1293.2012.01055.x. View

Torres T, Cardoso S, Velasque L, Marins L, de Oliveira M, Veloso V . Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life. Braz J Infect Dis. 2013; 17(3):324-31. PMC: 9427395. DOI: 10.1016/j.bjid.2012.10.024. View

Negin J, Martiniuk A, Cumming R, Naidoo N, Phaswana-Mafuya N, Madurai L . Prevalence of HIV and chronic comorbidities among older adults. AIDS. 2012; 26 Suppl 1:S55-63. PMC: 4404756. DOI: 10.1097/QAD.0b013e3283558459. View

10.

Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn P . Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY. J Urban Health. 2011; 88(3):507-16. PMC: 3126930. DOI: 10.1007/s11524-010-9540-7. View

11.

Metallidis S, Tsachouridou O, Skoura L, Zebekakis P, Chrysanthidis T, Pilalas D . Older HIV-infected patients--an underestimated population in northern Greece: epidemiology, risk of disease progression and death. Int J Infect Dis. 2013; 17(10):e883-91. DOI: 10.1016/j.ijid.2013.02.023. View

12.

Chuapai Y, Kiertiburanakul S, Malathum K, Sungkanuparph S . Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy. J Med Assoc Thai. 2007; 90(3):452-8. View

13.

Paula A, Falcao M, Pacheco A . Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Ther. 2013; 10(1):32. PMC: 3874610. DOI: 10.1186/1742-6405-10-32. View

14.

Lo Y, Chen M, Sheng W, Hsieh S, Sun H, Liu W . Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study. HIV Med. 2009; 10(5):302-9. DOI: 10.1111/j.1468-1293.2008.00687.x. View

15.

Aekplakorn W, Abbott-Klafter J, Khonputsa P, Tatsanavivat P, Chongsuvivatwong V, Chariyalertsak S . Prevalence and management of prehypertension and hypertension by geographic regions of Thailand: the Third National Health Examination Survey, 2004. J Hypertens. 2008; 26(2):191-8. DOI: 10.1097/HJH.0b013e3282f09f57. View

16.

Kendall C, Wong J, Taljaard M, Glazier R, Hogg W, Younger J . A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health. 2014; 14:161. PMC: 3933292. DOI: 10.1186/1471-2458-14-161. View

17.

Aekplakorn W, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Putwatana P, Sritara P . Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009. J Lipids. 2014; 2014:249584. PMC: 3985300. DOI: 10.1155/2014/249584. View

18.

Schouten J, Wit F, Stolte I, Kootstra N, Van Der Valk M, Geerlings S . Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014; 59(12):1787-97. DOI: 10.1093/cid/ciu701. View